Image

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This clinical trial compares a new smoking cessation smartphone application (app) (iCanQuit) to an existing smarphone app (National Cancer Institute [NCI] QuitGuide) for helping American Indians and Alaska Natives (AIANs) quit smoking. Compared to other racial/ethnic groups, AIANs have 6 times higher rates of developing smoking-related cancers, including lung cancer. Commercial cigarette smoking accounts for half of all deaths among AIANs nationwide. AIANs' often lack of access to smoking cessation interventions, which may be due to inequities in the healthcare system, lack of health insurance, living in rural areas, systemic racism, and historical trauma. There is also a lack of effective smoking cessation interventions for AIANs. Smartphone apps have the potential to deliver a low-cost smoking cessation intervention with wide reach to AIANs. Apps require no in-person delivery and no provider training, do not require integration into complex hospital systems, can be freely accessed on an app store, and are available at any time and any place. iCanQuit is a behavioral intervention designed to help adults stop smoking by teaching skills for coping with smoking urges, staying motivated, and preventing relapse. The iCanQuit app intervention may be more effective than the currently available NCI QuitGuide app at helping AIANs quit smoking.

Description

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors for at least 45 days on study.

ARM II: Participants use the NCI QuitGuide app for at least 45 days on study.

After completion of study intervention, patients are followed up at 3, 6, and 12-months.

Eligibility

Inclusion Criteria:

  • Self-identify as American Indian or Alaska Native, either alone or in combination with other races
  • Age 18 and older
  • Has smoked daily for the past year
  • Interest in quitting smoking within the next 30 days
  • Willing to be randomly assigned to either app
  • Have daily access to their own Android or iPhone
  • Able to download a smartphone app
  • Be willing and able to read English
  • Not currently or within past 30 days using other smoking cessation behavioral interventions or smoking cessation pharmacotherapies
  • Have never participated in our prior research
  • Have no other household or family member participating
  • Being willing to complete the 3, 6, and 12-month follow-up assessments
  • Providing email, phone number(s), and mailing address
  • Living off United States (US) AIAN tribal reservations or living on five Northern Plains tribal reservations from whom we would obtain approvals to recruit

Exclusion Criteria:

  • Currently (i.e., within past 30 days) using other smoking cessation behavioral interventions
  • Has participated in our prior research trials
  • Has used the National Cancer Institute's (NCI's) QuitGuide app
  • Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
  • Not providing email, phone number(s), and mailing address

Study details
    Cigarette Smoking-Related Carcinoma

NCT06145763

Fred Hutchinson Cancer Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.